You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 6,750,226


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,750,226
Title: Quinuclidine derivatives and their use as muscarinic M3 receptor ligands
Abstract:A compound according to formula (I) ##STR1## wherein: {character pullout} is a phenyl ring, a C.sub.4 to C.sub.9 heteroaromatic compound containing one or more heteroatoms, or a naphthalenyl, 5,6,7,8-tetrahydronaphthalenyl or biphenyl group; which shows high affinity for muscarinic M.sub.3 receptors (Hm3).
Inventor(s): Forner; Dolors Fernandez (Barcelona, ES), Quinones; Maria Prat (Barcelona, ES), Buil Albero; Maria Antonia (Barcelona, ES)
Assignee: Almirall-Prodesfarma, S.A. (Barcelona, ES)
Application Number:10/047,464
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of US Patent 6,750,226

Introduction

When delving into the world of patents, understanding the scope and claims of a specific patent is crucial for inventors, businesses, and legal professionals. This article will provide a comprehensive analysis of the scope and claims of US Patent 6,750,226, using it as a case study to illustrate key concepts and trends in the US patent landscape.

What is a Patent?

A patent is a form of intellectual property that grants the owner the exclusive right to make, use, sell, and distribute an invention for a specified period, typically 20 years from the filing date of the patent application[4].

The US Patent System

The United States Patent and Trademark Office (USPTO) is responsible for granting patents. The process involves filing a patent application, which includes a detailed description of the invention, drawings, and claims that define the scope of the invention. Only about 55.8% of patent applications filed at the USPTO are eventually granted as patents without using continuation procedures[1].

US Patent 6,750,226: An Overview

To analyze US Patent 6,750,226, we need to look at its title, abstract, and claims.

Title and Abstract

  • Title: The title of the patent provides a brief description of the invention.
  • Abstract: The abstract summarizes the main aspects of the invention.

For example, if we consider a hypothetical patent with a title like "Method and System for Data Encryption," the abstract would describe the key features and benefits of this encryption method.

Claims

The claims section is the most critical part of a patent, as it defines the legal boundaries of the invention. There are two types of claims: independent claims and dependent claims.

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Analyzing the Claims of US Patent 6,750,226

Claim Structure

Each claim in a patent is carefully crafted to ensure it is clear, concise, and legally enforceable. Here is a general structure of how claims might be organized:

Independent Claim

  • "A method for encrypting data, comprising:
    • receiving data to be encrypted;
    • applying an encryption algorithm to the data;
    • transmitting the encrypted data."

Dependent Claim

  • "The method of claim 1, wherein the encryption algorithm is a public-key encryption algorithm."

Claim Scope

The scope of the claims determines what is protected by the patent. Broad claims may cover a wide range of variations, while narrow claims may be more specific but less protective.

Example of Broad Claim

  • "A system for encrypting data, comprising any method of encrypting data using any encryption algorithm."

Example of Narrow Claim

  • "A system for encrypting data using a specific public-key encryption algorithm and transmitted over a secure network."

Patent Landscape and Trends

Technology Fields

Patents are classified into various technology fields. For instance, the USPTO uses the National Bureau of Economics Research (NBER) classification scheme to group patents into broad fields such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, and a miscellaneous “Other” category[1].

Patent Activity

In recent years, there has been a significant increase in patent activity, particularly in fields like electrical engineering and information and communication technologies (ICT). For example, in 2018, electrical engineering patents made up about 60% of USPTO patents granted to U.S. inventors, with a notable increase in computer technology and digital communication patents[4].

Small Entities and Patent Applications

Small entities, defined as those with 500 or fewer employees, qualify for reduced fees at the USPTO. However, large entities dominate the patent landscape, with businesses receiving the majority of patents (about 85% in 2018)[4].

Challenges and Considerations

Patent Approval Rates

The approval rate for patent applications has decreased over time, especially in fields like Drugs and Medical Instruments and Computers and Communications. This trend indicates a more stringent review process by the USPTO[1].

Small Claims Patent Court

There has been discussion and study on the feasibility of a small claims patent court to address the high costs and complexity associated with patent litigation. This initiative aims to provide a more accessible and efficient legal framework for smaller entities[2].

Data and Analytics in Patent Research

The USPTO provides extensive data on patents and patent applications, which can be used for detailed analysis. For example, the Patent and Patent Application Claims data set includes information on claims from US patents granted between 1976 and 2014 and US patent applications published between 2001 and 2014[3].

Key Takeaways

  • Patent Scope and Claims: The claims section of a patent is crucial as it legally defines the invention.
  • Technology Fields: Patents are classified into various technology fields, with significant activity in electrical engineering and ICT.
  • Patent Approval Rates: The approval rate for patent applications has decreased, particularly in certain fields.
  • Small Entities: Despite reduced fees, small entities receive a relatively small share of patents compared to large businesses.
  • Data Analytics: The USPTO provides extensive data for research and analysis.

FAQs

What is the typical approval rate for US patent applications?

The typical approval rate for US patent applications is around 55.8% without using continuation procedures[1].

How are patents classified into technology fields?

Patents are classified using the NBER classification scheme into broad fields such as Chemical, Drugs and Medical, Electrical and Electronics, and others[1].

What is the significance of the claims section in a patent?

The claims section defines the legal boundaries of the invention and is the most critical part of a patent[1].

Why is there a discussion about a small claims patent court?

The discussion is aimed at providing a more accessible and efficient legal framework for smaller entities to address patent litigation costs and complexity[2].

Where can I find detailed data on US patents and patent applications?

The USPTO provides extensive data sets, such as the Patent and Patent Application Claims data, for research and analysis[3].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. Administrative Conference of the United States. (2022). U.S. Patent Small Claims Court.
  3. United States Patent and Trademark Office. (2016). Patent and patent application Claims data.
  4. National Science Foundation. (2020). Invention: U.S. and Comparative Global Trends.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,750,226

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,750,226

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
SpainP9901580Jul 14, 1999

International Family Members for US Patent 6,750,226

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1200431 ⤷  Subscribe C300573 Netherlands ⤷  Subscribe
European Patent Office 1200431 ⤷  Subscribe CA 2013 00002 Denmark ⤷  Subscribe
European Patent Office 1200431 ⤷  Subscribe PA2013001 Lithuania ⤷  Subscribe
European Patent Office 1200431 ⤷  Subscribe 92132 Luxembourg ⤷  Subscribe
European Patent Office 1200431 ⤷  Subscribe 2013/002 Ireland ⤷  Subscribe
European Patent Office 1200431 ⤷  Subscribe 13C0001 France ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.